EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19

Diana Mota Toro iD, Pedro V da Silva-Neto iD, Jonatan C S de Carvalho iD, Carlos A Fuzo iD, Malena M Pérez, Vinícius E Pimentel iD, Thais F C Fraga-Silva iD, Camilla N S Oliveira, Glaucia R Caruso, Adriana F L Vilela, Pedro Nobre-Azevedo iD, Thiago V Defelippo-Felippe iD und 23 weitere

Cells · 2023

DOI: 10.3390/cells12151938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Diana Mota Toro und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeirão Preto-FCFRP, University of Sao Paul…. Hauptthemen laut MEDLINE: Sphingomyelins, COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo–FAPESP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 infection triggers distinct patterns of disease development characterized by significant alterations in host regulatory responses. Severe cases exhibit profound lung inflammation and systemic repercussions. Remarkably, critically ill patients display a “lipid storm”, influencing the inflammatory process and tissue damage. Sphingolipids (SLs) play pivotal roles in various cellular and tissue processes, including inflammation, metabolic disorders, and cancer. In this study, we employed high-resolution mass spectrometry to investigate SL metabolism in plasma samples obtained from control subjects (n = 55), COVID-19 patients (n = 204), and convalescent individuals (n = 77). These data were correlated with inflammatory parameters associated with the clinical severity of COVID-19. Additionally, we utilized RNAseq analysis to examine the gene expression of enzymes involved in the SL pathway. Our analysis revealed the presence of thirty-eight SL species from seven families in the plasma of study participants. The most profound alterations in the SL species profile were observed in patients with severe disease. Notably, a predominant sphingomyelin (SM d18:1) species emerged as a potential biomarker for COVID-19 severity, showing decreased levels in the plasma of convalescent individuals. Elevated SM levels were positively correlated with age, hospitalization duration, clinical score, and neutrophil count, as well as the production of IL-6 and IL-8. Intriguingly, we identified a putative protective effect against disease severity mediated by SM (d18:1/24:0), while ceramide (Cer) species (d18:1/24:1) and (d18:1/24:0)were associated with increased risk. Moreover, we observed the enhanced expression of key enzymes involved in the SL pathway in blood cells from severe COVID-19 patients, suggesting a primary flow towards Cer generation in tandem with SM synthesis. These findings underscore the potential of SM as a prognostic biomarker for COVID-19 and highlight promising pharmacological targets. By targeting sphingolipid pathways, novel therapeutic strategies may emerge to mitigate the severity of COVID-19 and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingomyelinsCOVID-19HumansPrognosisSARS-CoV-2CeramidesSphingolipidsBiomarkers

Stichwörter der Autor:innen

COVID-19biomarkerinflammationsphingolipidssphingomyelin

Substanzen

SphingomyelinsCeramidesSphingolipidsBiomarkers

Autor:innen und Institutionen

  • Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeirão Preto-FCFRP, University of Sao Paulo-USP, Ribeirão Preto 14040-903, SP, Brazil.
  • Postgraduate Program in Basic and Applied Immunology-PPGIBA, Institute of Biological Sciences, Federal University of Amazonas-UFAM, Manaus 69080-900, AM, Brazil.
  • Department of Chemistry, Faculty of Philosophy, Sciences and Letters of Ribeirão Preto-FFCLRP, University of São Paulo-USP, Ribeirão Preto 14040-901, SP, Brazil.
  • Department of Biochemistry and Immunology, Faculty of Medicine of Ribeirão Preto-FMRP, University of São Paulo-USP, Ribeirão Preto 14049-900, SP, Brazil.
  • Department of General and Specialized Nursing, School of Nursing of Ribeirão Preto-EERP, University of São Paulo-USP, Ribeirão Preto 14040-902, SP, Brazil.
  • Hospital Santa Casa de Misericórdia de Ribeirão Preto, Ribeirão Preto 14085-000, SP, Brazil.

ORCID-Profile: Diana Mota Toro, Pedro V da Silva-Neto, Jonatan C S de Carvalho, Carlos A Fuzo, Vinícius E Pimentel, Thais F C Fraga-Silva, Pedro Nobre-Azevedo, Thiago V Defelippo-Felippe, Rogerio S Parra, Fernando C Vilar, Gabriel P Costa, Elisa M S Russo, Vânia L D Bonato, Cristina R B Cardoso, Marcelo Dias-Baruffi, Átila A Trapé, Lúcia H Faccioli

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo–FAPESP
  • Coordination for the Improvement of Higher Educational Personnel
  • USP VIDA program
  • POSGRAD Program
  • Department of Veterans Affairs
  • National Council for Scientific and Technological Development-CNPq

Zitieren

APA

Toro, D. M., da Silva-Neto, P. V., de Carvalho, J. C. S., Fuzo, C. A., Pérez, M. M., Pimentel, V. E., Fraga-Silva, T. F. C., Oliveira, C. N. S., Caruso, G. R., Vilela, A. F. L., Nobre-Azevedo, P., Defelippo-Felippe, T. V., Argolo, J. G. M., Degiovani, A. M., Ostini, F. M., Feitosa, M. R., Parra, R. S., Vilar, F. C., Gaspar, G. G., …, & ImmunoCovid Consortium Group (2023). Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. Cells. https://doi.org/10.3390/cells12151938

Vancouver

Toro DM, da Silva-Neto PV, de Carvalho JCS, Fuzo CA, Pérez MM, Pimentel VE, et al. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. Cells. 2023. doi:10.3390/cells12151938

BibTeX
@article{Toro2023,
  author = {Toro, Diana Mota and da Silva-Neto, Pedro V and de Carvalho, Jonatan C S and Fuzo, Carlos A and Pérez, Malena M and Pimentel, Vinícius E and Fraga-Silva, Thais F C and Oliveira, Camilla N S and Caruso, Glaucia R and Vilela, Adriana F L and Nobre-Azevedo, Pedro and Defelippo-Felippe, Thiago V and Argolo, Jamille G M and Degiovani, Augusto M and Ostini, Fátima M and Feitosa, Marley R and Parra, Rogerio S and Vilar, Fernando C and Gaspar, Gilberto G and Rocha, José J R da and Feres, Omar and Costa, Gabriel P and Maruyama, Sandra R C and Russo, Elisa M S and Fernandes, Ana Paula M and Santos, Isabel K F M and Malheiro, Adriana and Sadikot, Ruxana T and Bonato, Vânia L D and Cardoso, Cristina R B and Dias-Baruffi, Marcelo and Trapé, Átila A and Faccioli, Lúcia H and Sorgi, Carlos A and ImmunoCovid Consortium Group},
  title = {Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12151938}
}
Kostenlos starten →